1. Home
  2. MYFW vs IMRX Comparison

MYFW vs IMRX Comparison

Compare MYFW & IMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MYFW

First Western Financial Inc.

N/A

Current Price

$30.90

Market Cap

312.1M

Sector

Finance

ML Signal

N/A

Logo Immuneering Corporation

IMRX

Immuneering Corporation

N/A

Current Price

$4.47

Market Cap

313.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MYFW
IMRX
Founded
2002
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
312.1M
313.8M
IPO Year
2018
2021

Fundamental Metrics

Financial Performance
Metric
MYFW
IMRX
Price
$30.90
$4.47
Analyst Decision
Hold
Strong Buy
Analyst Count
1
5
Target Price
$27.00
$17.20
AVG Volume (30 Days)
37.7K
624.6K
Earning Date
04-23-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
54.02
37.75
EPS
1.20
N/A
Revenue
$96,914,000.00
N/A
Revenue This Year
$20.48
N/A
Revenue Next Year
$9.70
N/A
P/E Ratio
$25.63
N/A
Revenue Growth
7.60
N/A
52 Week Low
$21.96
$3.86
52 Week High
$34.36
$10.08

Technical Indicators

Market Signals
Indicator
MYFW
IMRX
Relative Strength Index (RSI) 44.48 39.81
Support Level $30.08 $3.98
Resistance Level $31.24 $5.32
Average True Range (ATR) 0.74 0.22
MACD 0.00 -0.09
Stochastic Oscillator 19.77 17.32

Price Performance

Historical Comparison
MYFW
IMRX

About MYFW First Western Financial Inc.

First Western Financial Inc is a financial holding company that provides a fully integrated suite of wealth management services on its private trust bank platform, which includes a comprehensive selection of deposit, loan, trust, wealth planning, and investment management products and services. The company has two operating segments; The Wealth Management segment consists of operations relative to the Company's fully integrated wealth management products and services, and The Mortgage segment consists of operations relative to the Company's residential mortgage service offerings. The bank derives its majority revenue from the wealth management segment.

About IMRX Immuneering Corporation

Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.

Share on Social Networks: